These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 11093436
1. Activity indices in rheumatoid arthritis. Villaverde V, Balsa A, Cantalejo M, Fernández-Prada M, Madero MR, Muñoz-Fernández S, Gijón-Baños J, Martín-Mola E. J Rheumatol; 2000 Nov; 27(11):2576-81. PubMed ID: 11093436 [Abstract] [Full Text] [Related]
3. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria? El Miedany Y, Youssef SS, El Gaafary M. J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918 [Abstract] [Full Text] [Related]
4. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Pincus T, Strand V, Koch G, Amara I, Crawford B, Wolfe F, Cohen S, Felson D. Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413 [Abstract] [Full Text] [Related]
7. Why not use OSRA? A comparison of Overall Status in Rheumatoid Arthritis (RA) with ACR core set and other indices of disease activity in RA. Birrell FN, Hassell AB, Jones PW, Dawes PT. J Rheumatol; 1998 Sep; 25(9):1709-15. PubMed ID: 9733450 [Abstract] [Full Text] [Related]
12. Validity of single variables and indices to measure disease activity in rheumatoid arthritis. van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. J Rheumatol; 1993 Mar; 20(3):538-41. PubMed ID: 8097536 [Abstract] [Full Text] [Related]
13. A new disease activity index for rheumatoid arthritis: Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Mäkinen H, Kautiainen H, Hannonen P, Sokka T. J Rheumatol; 2008 Aug; 35(8):1522-7. PubMed ID: 18484699 [Abstract] [Full Text] [Related]
14. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry. de Punder YM, Fransen J, Kievit W, Houtman PM, Visser H, van de Laar MA, van Riel PL. Rheumatology (Oxford); 2012 Sep; 51(9):1610-7. PubMed ID: 22539487 [Abstract] [Full Text] [Related]
17. A simple index to assess disease activity in rheumatoid arthritis. Scott DL. J Rheumatol; 1993 Mar; 20(3):582-4. PubMed ID: 8478879 [Abstract] [Full Text] [Related]
18. Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis. Balsa A, Carmona L, González-Alvaro I, Belmonte MA, Tena X, Sanmartí R, EMECAR Study Group. J Rheumatol; 2004 Jan; 31(1):40-6. PubMed ID: 14705217 [Abstract] [Full Text] [Related]
19. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial. Sanmartí R, Marsal S, Valverde J, Casado E, Lafuente R, Kashiwagi N, Rodriguez-Cros JR, Erra A, Reina D, Gratacós J. Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997 [Abstract] [Full Text] [Related]